Archives
FDA Approves Farxiga for Diabetes Type-2
The U.S Food and Drug Administration has approved AstraZeneca drug Farxiga (dapaglifozin) to improve glucose control in people suffering from diabetes. The drug is to be used along with diet and exercise, the agency said Wednesday.
Latest Research Articles
Babies Can Distinguish Friendly and Unfriendly Relationships, Study Suggests
Mapping Study Aims to Save Dwindling Leatherback Turtle Populations
Americans are Drinking too Much but Most Doctors Aren't Doing Much to Help
Ontario Women Continue to Outlive Men as Number of Centenarians Grows
Pandora's Cluster Caught on Hubble's Camera as Part of Deep-space Probe
Animal Deaths Continue at Bonbin Surabaya, Indonesia's 'Zoo of Death'
4.4 Million-year-old 'Ardi' Skull Reveals Close Ties to Humans
During a Week of Volcanic Activity, Indonesia's Mt. Sinabung Erupted 77 Times in a Day
Cancer Death Rates Decline by 20 Percent Over Last 20 Years
Valproate Can give 'Perfect Pitch'
Researchers Study 'Shark Nursery' Fossils from Upper Midwest, Find Ancient Migration Route
8 Million Lives Saved Since Historic Anti-Smoking Report Released
MOST POPULAR
-
Weak Spot in Earth's Magnetic Field Raises Concerns for Humanity's Future
-
Spectacular Northern Lights Show Possible in 10 States as Geomagnetic Storm Approaches
-
Earth's Magnetic North Pole Shifts Toward Russia, Scientists Update Its Location
-
Undersea Volcano Off Oregon Coast Could Erupt in 2025 After Scientists Notice 'Swelling'
-
Mount Rainier's Volcanic Activity Closely Watched by Scientists
